Teladoc Health, Inc.
TDOC
$6.47
-$0.07-1.07%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.49B | 2.51B | 2.53B | 2.53B | 2.54B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.49B | 2.51B | 2.53B | 2.53B | 2.54B |
| Cost of Revenue | 772.59M | 772.29M | 771.59M | 763.47M | 756.04M |
| Gross Profit | 1.72B | 1.74B | 1.76B | 1.76B | 1.79B |
| SG&A Expenses | 1.23B | 1.26B | 1.28B | 1.30B | 1.32B |
| Depreciation & Amortization | 366.41M | 368.50M | 364.08M | 358.76M | 359.96M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.64B | 2.67B | 2.69B | 2.71B | 2.73B |
| Operating Income | -145.65M | -157.19M | -163.40M | -178.59M | -183.49M |
| Income Before Tax | -182.59M | -185.11M | -235.53M | -250.08M | -232.36M |
| Income Tax Expenses | -5.20M | -13.96M | -35.21M | -26.50M | -25.00M |
| Earnings from Continuing Operations | -177.40 | -171.15 | -200.32 | -223.59 | -207.36 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -177.40M | -171.15M | -200.32M | -223.59M | -207.36M |
| EBIT | -145.65M | -157.19M | -163.40M | -178.59M | -183.49M |
| EBITDA | 64.56M | 47.51M | 33.06M | 16.17M | 18.88M |
| EPS Basic | -0.99 | -0.96 | -1.14 | -1.28 | -1.19 |
| Normalized Basic EPS | -0.49 | -0.49 | -0.48 | -0.55 | -0.53 |
| EPS Diluted | -0.99 | -0.96 | -1.14 | -1.28 | -1.19 |
| Normalized Diluted EPS | -0.49 | -0.49 | -0.48 | -0.55 | -0.53 |
| Average Basic Shares Outstanding | 714.91M | 709.81M | 704.84M | 699.77M | 694.33M |
| Average Diluted Shares Outstanding | 714.91M | 709.81M | 704.84M | 699.77M | 694.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |